Works matching DE "ENTACAPONE"

Results: 90

Parkinson Treatment Approval.

Published in:

JAMA: Journal of the American Medical Association, 1999, v. 282, n. 21, p. 1995, doi. 10.1001/jama.282.21.1995-JFD90010-3-1

By:

Henney, Jane E.

Publication type:

Article

Efficacy and Safety of Adjuvant Treatment with Entacapone in Advanced Parkinson’s Disease with Motor Fluctuation: A Systematic Meta-Analysis.

Published in:

European Neurology, 2017, v. 78, n. 3/4, p. 143, doi. 10.1159/000479555

By:

Li, Jia;
Lou, Zhiwei;
Liu, Xiaoyang;
Sun, Yajuan;
Chen, Jiajun

Publication type:

Article

Comparison of pharmacokinetic profile of levodopa throughout the day between levodopa/carbidopa/entacapone and levodopa/carbidopa when administered four or five times daily.

Published in:

European Journal of Clinical Pharmacology, 2009, v. 65, n. 5, p. 443, doi. 10.1007/s00228-009-0622-y

By:

Kuoppamäki, Mikko;
Korpela, Kirsi;
Marttila, Reijo;
Kaasinen, Valtteri;
Hartikainen, Päivi;
Lyytinen, Jukka;
Kaakkola, Seppo;
Hänninen, Jutta;
Löyttyniemi, Eliisa;
Kailaj&x00E4;rvi, Marita;
Ruokoniemi, Päivi;
Ellmén, Juha

Publication type:

Article

Pharmacokinetics of entacapone, a peripherally acting catechol-O-methyltransferase inhibitor, in man: A study using a stable isotope technique.

Published in:

European Journal of Clinical Pharmacology, 2001, v. 56, n. 11, p. 821, doi. 10.1007/s002280000244

By:

Heikkinen, H.;
Saraheimo, M.;
Antila, S.;
Ottoila, P.;
Pentikauml;inen, P.J.

Publication type:

Article

Effect of entacapone on plasma homocysteine levels in Parkinson’s disease patients.

Published in:

Neurological Sciences, 2010, v. 31, n. 5, p. 565, doi. 10.1007/s10072-010-0262-0

By:

Nevrly, Martin;
Kanovsky, Petr;
Vranova, Hana;
Langova, Katerina;
Hlustik, Petr

Publication type:

Article

Clinical experience of tolcapone in advanced Parkinson’s disease.

Published in:

Neurological Sciences, 2008, v. 29, p. 380, doi. 10.1007/s10072-008-1052-9

By:

Canesi, Margherita;
Zecchinelli, Anna;
Pezzoli, Gianni;
Antonini, Angelo

Publication type:

Article

APPLICATION OF HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF LEVODOPA, CARBIDOPA, AND ENTACAPONE IN TABLET DOSAGE FORMS.

Published in:

Journal of Liquid Chromatography & Related Technologies, 2011, v. 34, n. 19, p. 2433, doi. 10.1080/10826076.2011.591024

By:

Issa, YousryM.;
Hassoun, MohamedE. M.;
Zayed, AshrafG.

Publication type:

Article

Role of tolcapone in the treatment of Parkinson's disease.

Published in:

Expert Review of Neurotherapeutics, 2007, v. 7, n. 12, p. 1649, doi. 10.1586/14737175.7.12.1649

By:

Leegwater-Kim, Julie;
Waters, Cheryl

Publication type:

Article

Cathecol-O-methyltransferase inhibitors: another possibly useful pharmacological tool for treating Parkinson's disease in pregnancy?

Published in:

2017

By:

Basile, Stefano;
Pinelli, Sara;
Garibaldi, Silvia;
Altamura, Claudia;
Calcagno, Marco;
Salerno, Maria Giovanna

Publication type:

journal article

Entacapone/Levodopa/Carbidopa Combination Tablet.

Published in:: Drugs in R&D, 2003, v. 4, n. 5, p. 310, doi. 10.2165/00126839-200304050-00006
Publication type:: Article

Pooled analysis of phase III with entacapone in Parkinson's disease.

Published in:

Acta Neurologica Scandinavica, 2014, v. 130, n. 4, p. 239, doi. 10.1111/ane.12278

By:

Kuoppamäki, M.;
Vahteristo, M.;
Ellmén, J.;
Kieburtz, K.

Publication type:

Article

Frequent administration of levodopa/carbidopa microtablets vs levodopa/carbidopa/entacapone in healthy volunteers.

Published in:

Acta Neurologica Scandinavica, 2013, v. 127, n. 2, p. 124, doi. 10.1111/j.1600-0404.2012.01700.x

By:

Nyholm, D.;
Ehrnebo, M.;
Lewander, T.;
Trolin, C. G.;
Bäckström, T.;
Panagiotidis, G.;
Spira, J.;
Nyström, C.;
Aquilonius, S.‐M.

Publication type:

Article

Efficacy of combining levodopa with entacapone on quality of life and activities of daily living in patients experiencing wearing-off type fluctuations.

Published in:

Acta Neurologica Scandinavica, 2005, v. 111, n. 1, p. 21, doi. 10.1111/j.1600-0404.2004.00363.x

By:

Reichmann, H.;
Boas, J.;
MacMahon, D.;
Myllyla, V.;
Hakala, A.;
Reinikainen, K.

Publication type:

Article

Efficacy and safety of entacapone in Parkinson's disease patients with suboptimal Levodopa response: a 6-month randomized placebo-controlled double-blind study in Germany and Austria (Celomen study).

Published in:

Acta Neurologica Scandinavica, 2002, v. 105, n. 4, p. 245, doi. 10.1034/j.1600-0404.2002.1o174.x

By:

Poewe, W. H;
Deuschl, G;
Gordin, A;
Kultalahti, E.-R;
Leinonen, M

Publication type:

Article

Is There a Difference between Levodopa/ Dopa-Decarboxylase Inhibitor and Entacapone and Levodopa/Dopa-Decarboxylase Inhibitor Dose Fractionation Strategies in Parkinson’s Disease Patients Experiencing Symptom Re-Emergence due to Wearing-Off?

Published in:

European Neurology, 2009, v. 61, n. 2, p. 69, doi. 10.1159/000177938

By:

Destée, Alain;
Rérat, Karin;
Bourdeix, Isabelle

Publication type:

Article

The Influence of Levodopa and the COMT Inhibitor on Serum Vitamin B12 and Folate Levels in Parkinson’s Disease Patients.

Published in:

European Neurology, 2007, v. 58, n. 2, p. 96, doi. 10.1159/000103644

By:

Triantafyllou, N. I.;
Kararizou, E.;
Angelopoulos, E.;
Tsounis, S.;
Boufidou, F.;
Evangelopoulos, M.;
Nikolaou, C.;
Vassilopoulos, D.

Publication type:

Article

Switch-Over from Tolcapone to Entacapone in Severe Parkinson’s Disease Patients.

Published in:

European Neurology, 2001, v. 46, n. 1, p. 11, doi. 10.1159/000050749

By:

Onofrj;
Thomas;
Iacono;
Di Iorio;
Bonanni

Publication type:

Article

Efficacy and Tolerability of Entacapone as Adjunctive Therapy to Levodopa in Patients with Parkinson’s Disease and End-of-Dose Deterioration in Daily Medical Practice: An Open, Multicenter Study.

Published in:

European Neurology, 2001, v. 45, n. 2, p. 111, doi. 10.1159/000052104

By:

Durif;
Devaux;
Pere;
Delumeau;
Bourdeix

Publication type:

Article

Immediate Versus Delayed Switch From Levodopa/Carbidopa to Levodopa/Carbidopa/Entacapone: Effects on Motor Function and Quality of Life in Patients With Parkinson's Disease With End-of-Dose Wearing Off.

Published in:

International Journal of Neuroscience, 2011, v. 121, n. 11, p. 605, doi. 10.3109/00207454.2011.598982

By:

Lew, Mark F.;
Somogyi, Monique;
McCague, Kevin;
Welsh, Mickie;
on behalf of the LCE QoL Study Group

Publication type:

Article

The Liver Toxicity Biomarker Study Phase I: Markers for the Effects of Tolcapone or Entacapone.

Published in:

Toxicologic Pathology, 2012, v. 40, n. 6, p. 951, doi. 10.1177/0192623312444026

By:

McBurney, Robert N.;
Hines, Wade M.;
VonTungeln, Linda S.;
Schnackenberg, Laura K.;
Beger, Richard D.;
Moland, Carrie L.;
Han, Tao;
Fuscoe, James C.;
Chang, Ching-Wei;
Chen, James J.;
Su, Zhenqiang;
Fan, Xiao-hui;
Tong, Weida;
Booth, Shelagh A.;
Balasubramanian, Raji;
Courchesne, Paul L.;
Campbell, Jennifer M.;
Graber, Armin;
Guo, Yu;
Juhasz, Peter

Publication type:

Article

Clinical pharmacology and therapeutic use of COMT inhibition in Parkinson's disease.

Published in:

Journal of Neurology, 2007, v. 254, p. IV37, doi. 10.1007/s00415-007-4007-9

By:

Gordin, Ariel;
Brooks, David

Publication type:

Article

Drug Repurposing Patent Applications October-December 2014.

Published in:

Assay & Drug Development Technologies, 2015, v. 13, n. 6, p. 325, doi. 10.1089/adt.2015.29016.patdrrr

By:

Mucke, Hermann A.M.

Publication type:

Article

Entacapone increases and prolongs the central effects ofl-DOPA in the 6-hydroxydopamine-lesioned rat.

Published in:

Naunyn-Schmiedeberg's Archives of Pharmacology, 2004, v. 370, n. 5, p. 388, doi. 10.1007/s00210-004-0984-8

By:

Gerlach, Manfred;
van den Buuse, Maarten;
Blaha, Charles;
Bremen, Dirk;
Riederer, Peter

Publication type:

Article

A prospective analysis of morphometry, electrode position in STN-DBS, and its motor outcomes in advanced Parkinson's disease -- An institutional study.

Published in:

2022

By:

Kolpakwar, Swapnil;
Alugolu, Rajesh;
Mudumba, Vijayasaradhi;
Arora, Abhishek;
Kandadai, Rukmini;
Borgohain, Rupam

Publication type:

Abstract

Study of Relative Association, Apparent Molar Compressibility and Free Length of Entacapone API in alcohols at different Frequencies.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2016, v. 50, n. 4, p. 703, doi. 10.5530/ijper.50.4.23

By:

Zade, Sachin Deorao;
Zade, Padma Sachin;
Ganjre, Pravin J.;
Aswale, Sunanda Shashikant;
Aswale, Shashikant Rajeshwar

Publication type:

Article

Dissolution Rate Enhancement of Entacapone and Formulation of its Oro-Dispersible Tablets: Applying Statistical Design.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2016, v. 50, n. 4, p. 549, doi. 10.5530/ijper.50.4.7

By:

Kumar, Mahapatra Anjan;
Murthy, Padala Narasimha;
Sameeraja, Nagampalli Haritha;
Narayan, Palei Narahari

Publication type:

Article

Entacapone promotes cAMP-dependent colonic Cl.

Published in:

Neurogastroenterology & Motility, 2011, v. 23, n. 7, p. 657, doi. 10.1111/j.1365-2982.2011.01715.x

By:

LI, L.-S.;
ZHENG, L.-F.;
XU, J.-D.;
JI, T.;
GUO, H.;
LI, X.-F.;
LI, Y.;
ZHANG, Y.;
ZHU, J.-X.

Publication type:

Article

Entacapone.

Published in:

Drugs, 1999, v. 58, n. 1, p. 159, doi. 10.2165/00003495-199958010-00017

By:

Holm, Kristin J.;
Spencer, Caroline M.

Publication type:

Article

AAN Releases Recommendations on Treatment of Parkinson's Disease.

Published in:

American Family Physician, 2007, v. 75, n. 6, p. 922

By:

Damlo, Sherri

Publication type:

Article

Levodopa/carbidopa/entacapone versus levodopa/ dopa-decarboxyiase inhibitor for the treatment of Parkinson’s disease: systematic review, metaanalysis, and economic evaluation.

Published in:

Therapeutics & Clinical Risk Management, 2018, v. 14, p. 709, doi. 10.2147/TCRM.S163190

By:

Yi, Zhan-Miao;
Qiu, Ting-Ting;
Zhang, Yuan;
Liu, Na;
Zhai, Suo-Di

Publication type:

Article

Analytical Methods for Determination of Entacapone in Pharmaceuticals and Urine.

Published in:

Eurasian Journal of Analytical Chemistry, 2015, v. 10, n. 3, p. 150

By:

Anubala, Sekar;
Sekar, Ramaiyan;
Nagaiah, Kommou

Publication type:

Article

A new synthesis of Entacapone and report on related studies.

Published in:

Journal of Chemical Sciences, 2015, v. 127, n. 11, p. 1977, doi. 10.1007/s12039-015-0961-4

By:

HARISHA, ATTIMOGAE;
NAYAK, SURESH;
S, PAVAN;
K, SHRIDHARA;
K, SUNDARRAJA;
K, RAJENDRA;
PARI, KOTEPPA;
H, SIVARAMKRISHNAN;
N, GURU;
NAGARAJAN, KUPPUSWAMY

Publication type:

Article

Thermal behavior of entacapone, a catechol-O-methyltransferase inhibitor used in Parkinson’s disease.

Published in:

Journal of Thermal Analysis & Calorimetry, 2018, v. 134, n. 1, p. 711, doi. 10.1007/s10973-018-7097-y

By:

Vlase, Titus;
Albu, Paul;
Ledeţi, Adriana;
Circioban, Denisa;
Mateescu, Mădălina;
Moşoiu, Codruţa;
Vlase, Gabriela

Publication type:

Article

Thermal decomposition kinetics of the antiparkinson drug 'entacapone' under isothermal and non-isothermal conditions.

Published in:

Journal of Thermal Analysis & Calorimetry, 2017, v. 130, n. 3, p. 2359, doi. 10.1007/s10973-017-6664-y

By:

Mohamed, Mona;
Atty, Shimaa;
Banks, Craig

Publication type:

Article

Use of the new levodopa agent Stalevo (levodopa/carbidopa/entacapone) in the treatment of Parkinson's disease in out-patient clinical practice (the START-M open trial).

Published in:

Neuroscience & Behavioral Physiology, 2008, v. 38, n. 9, p. 933, doi. 10.1007/s11055-008-9085-3

By:

Boiko, A. N.;
Batysheva, T. T.;
Minaeva, N. G.;
Babina, L. A.;
Vdovichenko, T. V.;
Zhuravleva, E. Yu.;
Shikhkerimov, R. K.;
Malykhina, E. A.;
Khozova, A. A.;
Zaitsev, K. A.;
Kostenko, E. V.

Publication type:

Article

Sleep attacks in Parkinson's disease induced by Entacapone, a COMT-inhibitor.

Published in:

Fundamental & Clinical Pharmacology, 2003, v. 17, n. 1, p. 121, doi. 10.1046/j.1472-8206.2003.00121.x

By:

Santens, Patrick

Publication type:

Article

Excessive daytime sleepiness and 'sleep attacks' induced by entacapone.

Published in:

Fundamental & Clinical Pharmacology, 2003, v. 17, n. 1, p. 113, doi. 10.1046/j.1472-8206.2003.00120.x

By:

Bareš, Martin;
Kaňovský, Petr;
Rektor, Ivan

Publication type:

Article

Levodopa dose maintenance or reduction in patients with Parkinson's disease transitioning to levodopa/carbidopa/entacapone.

Published in:

Neurology India, 2017, v. 65, n. 4, p. 746, doi. 10.4103/neuroindia.NI_597_16

By:

Jongkyu Park;
Younsoo Kim;
Jinyoung Youn;
Lee, Phil H.;
Sohn, Young H.;
Koh, Seoung B.;
Jee-Young Lee;
Baik, Jong S.;
Cho, Jin W.

Publication type:

Article

Effect of the Catechol-O-Methyltransferase Inhibitors Tolcapone and Entacapone on Fatty Acid Metabolism in HepaRG Cells.

Published in:

Toxicological Sciences, 2018, v. 164, n. 2, p. 477, doi. 10.1093/toxsci/kfy101

By:

Grünig, David;
Felser, Andrea;
Duthaler, Urs;
Bouitbir, Jamal;
Krähenbühl, Stephan

Publication type:

Article

An Impaired Immune Tolerance Animal Model Distinguishes the Potential of Troglitazone/Pioglitazone and Tolcapone/Entacapone to Cause IDILI.

Published in:

Toxicological Sciences, 2018, v. 161, n. 2, p. 412, doi. 10.1093/toxsci/kfx219

By:

Mak, Alastair;
Kato, Ryuji;
Weston, Kyle;
Hayes, Anthony;
Uetrecht, Jack

Publication type:

Article

Capture Compound Mass Spectrometry Sheds Light on the Molecular Mechanisms of Liver Toxicity of Two Parkinson Drugs.

Published in:

Toxicological Sciences, 2010, v. 113, n. 1, p. 243, doi. 10.1093/toxsci/kfp236

By:

Fischer, Jenny J.;
Michaelis, Simon;
Schrey, Anna K.;
Baessler, Olivia Graebner nee;
Glinski, Mirko;
Dreger, Mathias;
Kroll, Friedrich;
Koester, Hubert

Publication type:

Article

Entacapone augmentation of antipsychotic treatment in schizophrenic patients with negative symptoms; a double-blind placebo-controlled study.

Published in:

International Journal of Neuropsychopharmacology, 2014, v. 17, n. 2, p. 337, doi. 10.1017/S1461145713001387

By:

Kaphzan, Hanoch;
Ben-Shachar, Dorit;
Klein, Ehud

Publication type:

Article

Levodopa-carbidopa-entacapone overdose presenting as altered mental status, xanthoderma, and yellowish sclera.

Published in:

Signa Vitae, 2018, v. 14, n. 2, p. 75, doi. 10.22514/SV142.102018.12

By:

SUN HWA LEE;
SEONG JONG YUN;
SEOKYONG RYU;
SEUNG WOON CHOI;
HYE JIN KIM;
TAE KYUNG KANG;
SUNG CHAN OH;
SUK JIN CHO

Publication type:

Article

Nucleation Kinetics of Cis-Entacapone.

Published in:

Chemical & Biochemical Engineering Quarterly, 2012, v. 26, n. 3, p. 163

By:

Šamec, D. Škalec;
MeŠtrović, E.;
Sander, A.

Publication type:

Article

Drug Discovery Using Chemical Systems Biology: Repositioning the Safe Medicine Comtan to Treat Multi- Drug and Extensively Drug Resistant Tuberculosis.

Published in:

PLoS Computational Biology, 2009, v. 5, n. 7, p. 1, doi. 10.1371/journal.pcbi.1000423

By:

Kinnings, Sarah L.;
Liu, Nina;
Buchmeier, Nancy;
Tonge, Peter J.;
Lei Xie;
Bourne, Philip E.

Publication type:

Article

A Brazilian Football Player Still on the Pitch After 10 Years of Parkinson's Disease with Severe Freezing of Gait.

Published in:

Movement Disorders Clinical Practice, 2015, v. 2, n. 1, p. 43, doi. 10.1002/mdc3.12110

By:

Vale, Thiago Cardoso;
Pedroso, José Luiz;
Barsottini, Orlando Graziani;
Lees, Andrew John

Publication type:

Article

Validation of UV Spectrophotometric Method for Quantitative Determination of Entacapone in Tablets Using Experimental Design of Plackett-Burman for Robustness Evaluation and Comparison with HPLC.

Published in:

Analytical Letters, 2008, v. 41, n. 4, p. 571, doi. 10.1080/00032710801912730

By:

Paim, C.S.;
Gonçalves, H.;
Lange, A.;
Miron, D.;
Steppe, M.

Publication type:

Article

Determination of Entacapone by Differential Pulse Polarography in Pharmaceutical Formulation.

Published in:

Analytical Letters, 2008, v. 41, n. 1, p. 56, doi. 10.1080/00032710701746774

By:

Abasq, Marie‐Laurence;
Courtel, Patricia;
Burgot, Gwenola

Publication type:

Article

The use of entacapone in patients with advanced Parkinson's disease: 2 years' experience.

Published in:

Neurological Sciences, 2003, v. 24, n. 3, p. 197, doi. 10.1007/s10072-003-0128-9

By:

Paci, C.;
Sanguigni, S.;
Carboni, T.;
Gobbato, R.;
Curatola, L.

Publication type:

Article

Potential of microemulsified entacapone drug delivery systems in the management of acute Parkinson's disease.

Published in:

Journal of Acute Disease, 2016, v. 5, n. 4, p. 315, doi. 10.1016/j.joad.2016.05.004

By:

Vadlamudi, Harini Chowdary;
Yalavarthi, Prasanna Raju;
Mandava Venkata, Basaveswara Rao;
Thanniru, Jyotsna;
K.R., Vandana;
C.R., Sundaresan

Publication type:

Article